About: Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 31 May 2016

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2016 (ast) наукова стаття, опублікована в травні 2016 (uk) مقالة علمية نشرت في 31 مايو 2016 (ar) scientific article published on 31 May 2016 (en)
publication date	wds:Q37119998-68A4BFC8-6B54-4453-BD54-5BC01BF12220
publication date	2016-05-31 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37119998-90E2492A-C7B7-421E-A71B-2535001127CD
language of work or name	English
cites work	wds:Q37119998-05DDBBA8-3D68-40D9-BCF7-4B46262E01EF wds:Q37119998-136F283E-6810-44AE-80D4-2389FDC4E433 wds:Q37119998-1719289C-3C59-491F-AA11-94A9369E5117 wds:Q37119998-1BEF3530-04AE-43F0-BA85-7EC3AE764219 wds:Q37119998-248B77C0-74D5-4801-BAD7-BA4ED0C1DC41 wds:Q37119998-34E5916D-9C57-4BB6-9D53-8F4AFB10BE75 wds:Q37119998-3ECF246E-F955-4BE9-9566-FA7928B7D583 wds:Q37119998-52F87BEE-AB68-4E60-B0FC-F3E4CBECD61B wds:Q37119998-59E22CE7-52C8-4877-82A4-6CF8FF92BD04 wds:Q37119998-6A4AD77E-7B90-4A12-AE48-C9B1402E9F01 wds:Q37119998-6E4C29FB-B6D0-44D6-AE4B-5D970FB84377 wds:Q37119998-71407E51-8810-47E2-93D5-E824E9D1E516 wds:Q37119998-8C64C601-01A8-4659-AE92-D974961C4B37 wds:Q37119998-A50D07AF-B921-405B-B78B-07636724E3C3 wds:Q37119998-B1EB6B82-6D5B-4D7F-84D5-2BFD11937744 wds:Q37119998-B9CF4030-E3C0-4779-9651-1E59190CA4AD wds:Q37119998-BD4C0D53-8B3F-4982-BBB2-9D64EA0236C4 wds:Q37119998-BDEDACF6-5B53-49A8-B093-EFD7FA302D83 wds:Q37119998-C45B99F3-FAA2-4C57-907E-CC6C34D7ACDC wds:Q37119998-C956C82B-E85D-4748-B0D8-9F5C40CA0016 wds:Q37119998-CB4B8F92-1FB4-4377-9630-93C5AD7B298B wds:Q37119998-D268FA55-AC7C-4948-AC99-FDA2E6C60C37 wds:Q37119998-D98DAA1C-F56F-4769-B78B-84AA355834F7 wds:Q37119998-E4A2430F-EBA5-47AD-A367-59DD1AA9C85C wds:Q37119998-E531B9E4-E87C-47B3-808B-1E53A4621871 wds:Q37119998-E5EF3FC5-C013-4329-B0D0-EDE9E78869DA wds:Q37119998-E734D0E7-47C5-4395-9CAF-8DB03607E947 wds:Q37119998-E90610A4-F9BF-4CE3-B732-DF1AB19BFDD6
cites work	The WHO 2014 global tuberculosis report--further to go. Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability Serum drug concentrations predictive of pulmonary tuberculosis outcomes Mycobacterial cell wall: structure and role in natural resistance to antibiotics MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. The pyrazinamide susceptibility breakpoint above which combination therapy fails Redefining multidrug-resistant tuberculosis based on clinical response to combination therapy A new evolutionary and pharmacokinetic-pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance Reevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing Pulmonary resection in the treatment of 43 patients with well-localized, cavitary pulmonary multidrug-resistant tuberculosis in Shanghai Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng, South Africa Classification of EEG spatial patterns with a tree-structured methodology: CART. Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data Association of drug susceptibility testing results for first- and second-line drugs with treatment outcomes in patients with multidrug-resistant and extensively drug-resistant tuberculosis. Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamide Factors associated with treatment outcome in 64 HIV negative patients with multidrug resistant tuberculosis Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System. Predictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005-2012 Outcome of multi-drug resistant tuberculosis cases treated by individualized regimens at a tertiary level clinic. Fluoroquinolone resistance in non-multidrug-resistant tuberculosis-a surveillance study in New South Wales, Australia, and a review of global resistance rates
author name string	wds:Q37119998-281AB6F2-4E7A-478D-A5F6-19167FC041E7 wds:Q37119998-3DED795C-E0A8-45C9-B3CA-17F2D09F5531 wds:Q37119998-84166BE8-BB9C-481E-BDCE-95C3C0B5237E wds:Q37119998-D2CC8E13-56E0-41A7-813D-99B6B0E36873 wds:Q37119998-F435A20F-A24D-44A3-9042-A93C02D25A1C wds:Q37119998-F4BB28B0-CDA1-458A-9E0B-E9EB508C9875 wds:Q37119998-F9FA6BAC-CA32-42D1-BC91-3D5CDC867836
author name string	Sven Hoffner Jim Werngren Yi Hu Xubin Zheng Mikael Mansjö Rongrong Zheng Lina Davies Forsman
rdfs:label	Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China (en) Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China (nl) Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China (ast)
skos:prefLabel	Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China (en) Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China (nl) Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China (ast)
name	Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China (en) Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China (nl) Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China (ast)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software